# US 2017/0253929 A1 · Novel Homeobox Gene

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0253929 A1
- Document ID: US20170253929A1
- Status: Published application
- Kind: A1
- Application number: 15/463,481
- Filed: 2017-03-20
- Published: 2017-09-07
- Earliest claimed: 2001-11-26
- Assignees: Central Adelaide Local Health Network Incorporated
- Applicants: Central Adelaide Local Health Network Incorporated
- Inventors: Jozef Gecz; Petter Stromme
- Web page: https://patentgrep.com/patent/US20170253929A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C07K 14/47: from mammals
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO: 1.

## Claims

### Claim at position 1

-24. (canceled)

### Claim 25

A nucleic acid probe comprising a fragment of a human Aristaless homeobox (ARX) gene sequence or the complementary sequence thereof, wherein the ARX sequence has the sequence of SEQ ID NO: 1, and comprises a mutation selected from the group consisting of a 24 bp duplication coding for 8 additional alanine residues in the polyalanine tract and a 1058C>T missense mutation; and
wherein the nucleic acid probe specifically binds under high stringency conditions to the ARX sequence, and wherein the nucleic acid probe is detectably labeled.

### Claim 26 (depends on 25)

The nucleic acid probe of claim 25, wherein the mutation in the ARX sequence comprises a 24 bp duplication coding for 8 additional alanine residues.

### Claim 27 (depends on 25)

The nucleic acid probe of claim 25, wherein the mutation in the ARX sequence comprises a 1058C>T missense mutation.

### Claim 28 (depends on 25)

The nucleic acid probe of claim 25, wherein the nucleic acid probe is labeled with a radioactive label or fluorescent label.

### Claim 29 (depends on 25)

The nucleic acid probe of claim 25, wherein the probe is 10 to 10,000 nucleotides in length.

### Claim 30 (depends on 25)

The nucleic acid probe of claim 25, wherein the probe is 50 to 1000 nucleotides in length.

### Claim 31 (depends on 25)

The nucleic acid probe of claim 25, wherein the probe is 100 to 1000 nucleotides in length.

### Claim 32 (depends on 25)

The nucleic acid probe of claim 25, wherein the probe is 10 to 25 nucleotides in length.

### Claim 33 (depends on 25)

The nucleic acid probe of claim 25, wherein the probe is 10 to 50 nucleotides in length.

### Claim 34 (depends on 25)

The nucleic acid probe of claim 25, wherein the probe is 10 to 100 nucleotides in length.

### Claim 35 (depends on 25)

The nucleic acid probe of claim 25, wherein the probe comprises a sequence selected from SEQ ID NOs: 5-7.

### Claim 36 (depends on 25)

An array for detecting a mutation in ARX nucleic acid, comprising the nucleic acid probe of claim 25.

### Claim 37 (depends on 36)

The array of claim 36, further comprising one or more primers selected from SEQ ID NOs: 12 to 25.
